Business / Finance

RSS

Helsinn Group grants GEN Ilaç anamorelin rights for Turkey

Helsinn Group, the company focused on building quality cancer care, today announces that rights to anamorelin, its innovative ghrelin receptor agonist, have been granted in Turkey to GEN Ilaç.

30 Jun 2014

ARC Healthcare to continue payment of monthly distributions at $0.68 per share

American Realty Capital Healthcare Trust, Inc. ("ARC Healthcare") announced today that, pursuant to the prior authorization of its board of directors, ARC Healthcare intends to continue payment of monthly distributions at an annualized rate of $0.68 per share.

28 Jun 2014

Valent Biosciences opens new biorational manufacturing facility in Iowa

Valent BioSciences Corporation (VBC) today marked the official opening of its new $146 million biorational manufacturing facility in Osage, IA in a ceremony that included more than 130 international dignitaries, state and local VIPs, and media personnel.

28 Jun 2014

Kerr acquires DUX Dental and Vettec to expand product portfolio

Kerr Corporation, a global manufacturer of dental products, announced today that it has acquired DUX Dental and Vettec Inc. to further expand its product portfolio and to better serve dental professionals and healthcare providers globally.

28 Jun 2014

China Biologic prices follow-on offering of common stock at $38.00 per share

China Biologic Products, Inc., a leading plasma-based biopharmaceutical company in China, today announced the pricing of a follow-on offering of 1,550,000 shares of common stock at a public offering price of $38.00 per share.

27 Jun 2014

Auxilium Pharmaceuticals plans to merge with QLT

Auxilium Pharmaceuticals, Inc., a fully integrated specialty biopharmaceutical company, and QLT Inc., a Canadian-based biotechnology company focused on developing innovative orphan ophthalmology products, today announced that they have entered into a definitive agreement under which Auxilium plans to merge with QLT.

26 Jun 2014

Opal Aged Care signs agreement to acquire Stockland's aged care portfolio

Today, Opal Aged Care (formerly Domain Principal Group) and Stockland announced an agreement for Opal Aged Care to acquire Stockland's aged care portfolio. The acquisition signals the start of a longer term partnership through cooperation on future co-located retirement living and aged care sites.

25 Jun 2014

Owens & Minor signs definitive agreement to acquire Medical Action Industries

Owens & Minor, Inc., a leading healthcare logistics company, and Medical Action Industries Inc., a leading producer of custom procedure trays (CPTs) and minor procedure kits, announced today that the two companies have signed a definitive agreement under which Owens & Minor will acquire all outstanding shares of Medical Action for $13.80 per share in cash, representing a total transaction value of approximately $208 million, including assumed debt, net of cash.

25 Jun 2014

Arcam receives order from DiSanto Technology for two Arcam Q10 systems

Arcam, listed on NASDAQ OMX, has received an order for two Arcam Q10 systems from the strategic partner DiSanto Technology Inc. in the US. The systems will be used for manufacturing of orthopedic implants.

24 Jun 2014

Ligand Pharmaceuticals, TG Therapeutics sign global license agreement for IRAK-4 inhibitors

Ligand Pharmaceuticals Incorporated announced the signing of an exclusive global license agreement with TG Therapeutics, Inc. for the development and commercialization of Ligand's Interleukin-1 Receptor Associated Kinase-4 (IRAK-4) inhibitors.

24 Jun 2014

FEI announces the sale of a complete correlative workflow to the University of Maastricht

FEI (NASDAQ: FEIC) announces the sale of a complete correlative workflow to the University of Maastricht. The systems will be installed at the University’s Institute of Nanoscopy, a new research facility that will use the high-resolution microscopes to understand the working mechanisms of protein complexes in an effort to develop new and improved treatment and prevention for disease, such as cancer and tuberculosis.

23 Jun 2014

Dimension Therapeutics closes $30M financing to advance novel gene therapy programs

Dimension Therapeutics, a gene therapy company focused on developing novel treatments for rare diseases, today announced the closing of a $30 million financing.

23 Jun 2014

Definiens closes €15M financing round to expand into digital tissue diagnostics

Definiens AG, which offers a unique approach to tissue diagnostics aimed at helping physicians improve treatment, said that it has closed a round of financing for € 15 million.

23 Jun 2014

Premier PHC, Encompass partner to improve patient outcomes

Premier Patient Health Care and Encompass Home Health & Hospice are pleased to announce a new partnership that actively manages the quality and cost of care for patients across multiple settings, in order to meet quality benchmarks and improve patient outcomes.

21 Jun 2014

Celsion acquires all assets of EGEN

Celsion Corporation, an oncology drug development company, today announced the completion of the acquisition by Celsion of substantially all of the assets of EGEN, Inc., a privately-held biopharmaceutical company focused on the development of nucleic acid-based therapeutics for the treatment of cancer and other difficult to treat diseases.

21 Jun 2014

Neovasc's common shares to commence trading on TSX

Neovasc Inc. ("Neovasc" or the "Company") today announced that effective at market opening on June 23, 2014, Neovasc's common shares will commence trading on the Toronto Stock Exchange (the "TSX") under the Company's current trading symbol of "NVC".

20 Jun 2014

Merck commences cash tender offer to purchase Idenix Pharmaceuticals

Merck, known as MSD outside the United States and Canada, is commencing today, through a subsidiary, a cash tender offer to purchase all outstanding shares of common stock of Idenix Pharmaceuticals, Inc. On June 09, 2014, Merck announced its intent to acquire Idenix.

20 Jun 2014

Peakdale Molecular reports significant growth in demand for its medicinal chemistry services

Peakdale Molecular, a leading UK provider of medicinal chemistry and chemistry services, is celebrating its most successful year ever for revenues and earnings since the company’s inception in 1992.

19 Jun 2014

Agfa HealthCare Corp. and OnBase by Hyland integrate best-in-class enterprise imaging and enterprise content management technologies to optimize the EHR

Agfa HealthCare Corp. announced today a new collaboration with OnBase to integrate the "gold standards" in enterprise imaging and enterprise content management technologies to showcase the vast potential of a fully integrated, "document + image" electronic health record (EHR).

19 Jun 2014